GeneDx Holdings (WGS) Operating Margin (2020 - 2026)

GeneDx Holdings has disclosed Operating Margin across 7 years of filings, most recently posting 56.2% for Q1 2026.

• In Q1 2026, Operating Margin fell 5098.0% year-over-year to 56.2%; the TTM figure through Mar 2026 stood at 14.91% (down 1064.0% YoY), while the FY2025 annual figure was 3.06%, up 454.0% from the prior year.
• Operating Margin eased to 56.2% in Q1 2026, from 11.77% in the prior quarter.
• Over the last five years, Operating Margin for WGS reached as high as 9.21% in Q4 2024 and fell as low as 529.56% in Q4 2022.
• The 5-year median for Operating Margin is 44.66% (2023), against an average of 101.77%.
• Annual changes were most pronounced in 2022 — Operating Margin tumbled 35302 bps — and 2023, when it surged 48489 bps.
• A 5-year view of Operating Margin shows it stood at 529.56% in 2022, then soared by 92 bps to 44.66% in 2023, then surged by 121 bps to 9.21% in 2024, then slumped by 228 bps to 11.77% in 2025, then plunged by 378 bps to 56.2% in 2026.
• According to Business Quant data, Operating Margin over the past three periods registered 56.2%, 11.77%, and 2.78% for Q1 2026, Q4 2025, and Q3 2025 respectively.